Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon May 01, 2009 3:29pm
836 Views
Post# 15960562

RE: RE: Reasons why RVX is south to $1.50 by year

RE: RE: Reasons why RVX is south to $1.50 by yearI love it when some idiot makes a statement that I'm a pumper and then uses a quote of mine that proves the exact opposite to be true. Intelligence, real intelligence, is very rare.$0$0$0$0So rather than have this poster, bone-something, explain Amorak, how about having Amorak explain Amorak.$0$0$0$0$0It will take 18 to 24 months to prove the science up to, but not including, Phase III. That's obvious.$0$0$0$0$0But we have Phases 1b and 2a to be reported soon. These trials will further derisk the stock, for good or bad. The market, at today's price, is expecting for the good.$0$0$0$0$0There are no events expected that would cause the stock to drop or to go up. The financing is done and the trials are planned so news is more or less scheduled. The participants in the financing, the size of their investment and the placement of the participant on the BOD is a signal that trials 1b and 2a should be successful.$0$0$0$0$0If the stock drops, it will because of investor impatience and fear, not because of anything material.$0$0$0$0$0So it's unlikely that the stock will drop to $1.50. If you want to see 100,000 shares bought real fast, just watch what happens when there's a margin call or a couple of investors who want to sell or have to sell dump in quantity. There's a big bucket waiting there for cheaper shares. It has trouble getting under $2.70 or so.$0$0$0$0$0So the bones and boneheads can rumble on all they want, they can throw crap on the wall to see if it sticks but in the end, they have nothing original to say, no logic to offer, no due diligence to present. It's just blah blah blah.$0$0$0$0$0I will continue to hold the stock until my own opinion is satisfied that it's time to sell. I will also continue to state as much reality as I can, pro or con.$0$0$0$0$0So be careful who you quote, bonehead.$0
Bullboard Posts